Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac vs Epiduo in Facial Acne Vulgaris
NCT00757523Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2008
- Primary completion
- Apr 2009
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of clindamycin and benzoyl peroxide + sulfur in acne vulgaris (2 arms), sponsored by GSK. Primary endpoint: Percent change in inflammatory lesion count from Baseline to Week 12. Started Sep 2008; status: completed.
02
Drugs
clindamycinbenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00757523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757523.